Cann Group Limited (FRA:CVJ)

Market Cap	10.03M
Revenue (ttm)	7.40M
Net Income (ttm)	-12.47M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,500
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0150
Beta	n/a
RSI	48.14
Earnings Date	Feb 26, 2026

About Cann Group

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Country: Australia
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: CVJ

Financial Performance

In 2025, Cann Group's revenue was 13.25 million, a decrease of -27.81% compared to the previous year's 18.36 million. Losses were -22.35 million, -56.39% less than in 2024.

Financial numbers in AUD